-
Innovation Ranking
NewInnovation Ranking – 9 Meters Biopharma Inc
9 Meters Biopharma Inc (9 Meters Biopharma), formerly Innovate Biopharmaceuticals Inc, is a clinical-stage biopharmaceutical company developing novel medicines for autoimmune and inflammatory diseases. The company’s pipeline products include Larazotide, an orally administered, gut-restricted tight-junction regulator for celiac disease, NM-003, a long-acting GLP-2 analog, under orphan indication selection, NM-136 and NM-004. 9 Meters Biopharma is headquartered in Raleigh, North Carolina, the US.
-
Product Insights
Cottontail Solar Farm 9, US
Cottontail Solar Farm 9 is proposed to be developed in Pennsylvania, United States. Empower your strategies with our Cottontail Solar Farm 9 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Product Insights
Litoral Piauiense Solar PV Project 9, Brazil
Litoral Piauiense Solar PV Project 9 is proposed to be built in Piaui, Brazil. The project is at the permitting stage. Empower your strategies with our Litoral Piauiense Solar PV Project 9 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Phosphodiesterase 9 – Drugs In Development, 2023
Global Markets Direct’s Phosphodiesterase 9 provides in depth analysis on Phosphodiesterase 9 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Phosphodiesterase 9 targeted therapeutics development and features...
-
Product Insights
Caspase 9 – Drugs In Development, 2023
Global Markets Direct’s Caspase 9 provides in depth analysis on Caspase 9 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Caspase 9 targeted therapeutics development and features...
-
Product Insights
Matrix Metalloproteinase 9 – Drugs In Development, 2023
Global Markets Direct’s Matrix Metalloproteinase 9 provides in depth analysis on Matrix Metalloproteinase 9 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Matrix Metalloproteinase 9 targeted therapeutics...
-
Product Insights
Cyclin Dependent Kinase 9 – Drugs In Development, 2023
Global Markets Direct’s Cyclin Dependent Kinase 9 provides in depth analysis on Cyclin Dependent Kinase 9 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Cyclin Dependent Kinase...
-
Product Insights
Toll Like Receptor 9 – Drugs In Development, 2023
Global Markets Direct’s Toll Like Receptor 9 provides in depth analysis on Toll Like Receptor 9 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Toll Like Receptor...
-
Product Insights
Proprotein Convertase Subtilisin/Kexin Type 9 – Drugs In Development, 2023
Global Markets Direct’s Proprotein Convertase Subtilisin/Kexin Type 9 provides in depth analysis on Proprotein Convertase Subtilisin/Kexin Type 9 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Proprotein...